Cargando…
The older, the less potential benefit for type 2 diabetes from weight control
BACKGROUND: Although moderate weight loss improves outcomes of type 2 diabetes mellitus (T2DM) in young and middle-aged adults, there is a lack of high-quality evidence to support the strong relationship between obesity and T2DM in older people. This study aims to investigate whether the association...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022304/ https://www.ncbi.nlm.nih.gov/pubmed/35443612 http://dx.doi.org/10.1186/s12877-022-02979-8 |
_version_ | 1784690052939382784 |
---|---|
author | Zhou, Qi Sun, Jie Wu, Zhu Wu, Wenbin Zhang, Xianbo Pan, Qi Qi, Haimei Yuan, Huiping Shi, Hong Cao, Suyan Yang, Ze Wang, Xiaoxia Sun, Liang |
author_facet | Zhou, Qi Sun, Jie Wu, Zhu Wu, Wenbin Zhang, Xianbo Pan, Qi Qi, Haimei Yuan, Huiping Shi, Hong Cao, Suyan Yang, Ze Wang, Xiaoxia Sun, Liang |
author_sort | Zhou, Qi |
collection | PubMed |
description | BACKGROUND: Although moderate weight loss improves outcomes of type 2 diabetes mellitus (T2DM) in young and middle-aged adults, there is a lack of high-quality evidence to support the strong relationship between obesity and T2DM in older people. This study aims to investigate whether the association of obesity with T2DM changes with aging. METHODS: In this cross-sectional study, we recruited 63,180 Chinses and US subjects from 3 datasets. Subjects were divided into young & middle-aged (≤59 years), young-old (60–75 years), and old-old (≥75 years). Logistic regression was used to determine the odds ratio (OR) and 95% confidence intervals (95% CI) for the association between obesity and T2DM, stratified by common confounders. A sliding-window based algorithm and restricted cubic splines were used to smoothly estimate the changes with aging. RESULTS: The OR (95% CI) for the associations between general obesity and T2DM were decreased from the young & middle-aged group (OR, 5.91; 95% CI, 5.33–6.56) to the young-old group (OR, 3.98; 95% CI, 3.56–4.45) and then to the old-old group (OR, 3.06; 95% CI, 2.57–3.66). The trend for this reduced association with aging persisted after stratification by obesity type, region, gender, recruiting time, hypertension, and hyperlipidemia in both Chinese and Americans. We also identified a weakened gender disparity for this association between the young & middle-aged subjects (P for disparity < 0.001) and the old-old group (P for disparity = ~ 0.36). CONCLUSIONS: The obesity-T2DM association is clearly reduced with aging, which indicates that the elderly may gain fewer potential benefits in weight lose than the younger patients. Considering this attenuated association, as well as the increased incidence of geriatric syndrome in the elderly, clinicians should comprehensively balance the benefits and side effects of weight loss in geriatric T2DM interventions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-022-02979-8. |
format | Online Article Text |
id | pubmed-9022304 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-90223042022-04-22 The older, the less potential benefit for type 2 diabetes from weight control Zhou, Qi Sun, Jie Wu, Zhu Wu, Wenbin Zhang, Xianbo Pan, Qi Qi, Haimei Yuan, Huiping Shi, Hong Cao, Suyan Yang, Ze Wang, Xiaoxia Sun, Liang BMC Geriatr Research BACKGROUND: Although moderate weight loss improves outcomes of type 2 diabetes mellitus (T2DM) in young and middle-aged adults, there is a lack of high-quality evidence to support the strong relationship between obesity and T2DM in older people. This study aims to investigate whether the association of obesity with T2DM changes with aging. METHODS: In this cross-sectional study, we recruited 63,180 Chinses and US subjects from 3 datasets. Subjects were divided into young & middle-aged (≤59 years), young-old (60–75 years), and old-old (≥75 years). Logistic regression was used to determine the odds ratio (OR) and 95% confidence intervals (95% CI) for the association between obesity and T2DM, stratified by common confounders. A sliding-window based algorithm and restricted cubic splines were used to smoothly estimate the changes with aging. RESULTS: The OR (95% CI) for the associations between general obesity and T2DM were decreased from the young & middle-aged group (OR, 5.91; 95% CI, 5.33–6.56) to the young-old group (OR, 3.98; 95% CI, 3.56–4.45) and then to the old-old group (OR, 3.06; 95% CI, 2.57–3.66). The trend for this reduced association with aging persisted after stratification by obesity type, region, gender, recruiting time, hypertension, and hyperlipidemia in both Chinese and Americans. We also identified a weakened gender disparity for this association between the young & middle-aged subjects (P for disparity < 0.001) and the old-old group (P for disparity = ~ 0.36). CONCLUSIONS: The obesity-T2DM association is clearly reduced with aging, which indicates that the elderly may gain fewer potential benefits in weight lose than the younger patients. Considering this attenuated association, as well as the increased incidence of geriatric syndrome in the elderly, clinicians should comprehensively balance the benefits and side effects of weight loss in geriatric T2DM interventions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-022-02979-8. BioMed Central 2022-04-20 /pmc/articles/PMC9022304/ /pubmed/35443612 http://dx.doi.org/10.1186/s12877-022-02979-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zhou, Qi Sun, Jie Wu, Zhu Wu, Wenbin Zhang, Xianbo Pan, Qi Qi, Haimei Yuan, Huiping Shi, Hong Cao, Suyan Yang, Ze Wang, Xiaoxia Sun, Liang The older, the less potential benefit for type 2 diabetes from weight control |
title | The older, the less potential benefit for type 2 diabetes from weight control |
title_full | The older, the less potential benefit for type 2 diabetes from weight control |
title_fullStr | The older, the less potential benefit for type 2 diabetes from weight control |
title_full_unstemmed | The older, the less potential benefit for type 2 diabetes from weight control |
title_short | The older, the less potential benefit for type 2 diabetes from weight control |
title_sort | older, the less potential benefit for type 2 diabetes from weight control |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022304/ https://www.ncbi.nlm.nih.gov/pubmed/35443612 http://dx.doi.org/10.1186/s12877-022-02979-8 |
work_keys_str_mv | AT zhouqi theolderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT sunjie theolderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT wuzhu theolderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT wuwenbin theolderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT zhangxianbo theolderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT panqi theolderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT qihaimei theolderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT yuanhuiping theolderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT shihong theolderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT caosuyan theolderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT yangze theolderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT wangxiaoxia theolderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT sunliang theolderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT zhouqi olderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT sunjie olderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT wuzhu olderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT wuwenbin olderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT zhangxianbo olderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT panqi olderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT qihaimei olderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT yuanhuiping olderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT shihong olderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT caosuyan olderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT yangze olderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT wangxiaoxia olderthelesspotentialbenefitfortype2diabetesfromweightcontrol AT sunliang olderthelesspotentialbenefitfortype2diabetesfromweightcontrol |